Portfolio company
Centivax
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops broad-spectrum vaccines and monoclonal antibodies using computational immune engineering to protect against infectious diseases and pathogens for global healthcare systems.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
CoVBio
The company develops broad-spectrum vaccines and therapeutic antibodies to protect the global population against coronaviruses and other respiratory viral infections.
Astrivax
This biopharmaceutical company develops thermostable vaccines and immunotherapies to prevent or treat infectious diseases and virus-driven cancers for patients worldwide.
Baseimmune
The company develops AI-designed vaccines and antigens for pharmaceutical partners and biotech researchers to treat infectious diseases and chronic conditions in humans and animals.
Affinivax
This biopharmaceutical company develops vaccines against infectious diseases and hospital-associated infections for healthcare providers and public health organisations worldwide.
GIVAX
This biotechnology company develops oral mucosal vaccines to protect children and adults against gastrointestinal diseases like rotavirus and norovirus.
Vaxdyn
Vaxdyn develops multivalent vaccines to prevent antibiotic-resistant bacterial infections for high-risk populations, including hospital patients and those with chronic diseases.
Aerium Therapeutics
This biopharmaceutical company develops monoclonal antibodies and antiviral treatments to protect immunocompromised patients against COVID-19 and future epidemic threats.
Radiant Biotherapeutics
This company develops multi-specific antibody therapies to treat patients with cancer and infectious diseases.
